Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03959969Completed
Randomised, open-label trial (2 arms), sponsored by MedStar Health Research Institute. Primary endpoint: Number of oxycodone tablets used at 14 days. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03959969.